Makie Taal

1.5k citations
18 papers · 822 indexed · h-index 13
Topics
Hepatitis B Virus Studies (8 papers)Liver Disease Diagnosis and Treatment (7 papers)Hepatitis C virus research (6 papers)

In The Last Decade

Makie Taal

18 papers receiving 805 citations

Peers

Makie Taal
Comparison fields: 5 of 75
  • Epidemiology 509
  • Hepatology 479
  • Public Health, Environmental and Occupational Health 196
  • Infectious Diseases 74
  • Pediatrics, Perinatology and Child Health 65
Replace Leila Maria Moreira Beltrão Pereira with:
Leila Maria Moreira Beltrão Pereira Brazil
Cesar de Almeida‐Neto Brazil
Zaccheaus Awortu Jeremiah Nigeria
Hui Zheng China
Celso Spada Brazil
Tégwindé Rébeca Compaore Burkina Faso
Masaaki Shimada Japan
Arício Treitinger Brazil
Julian Gabor Germany
Daniele Serranti Italy
Makie Taal relative to Leila Maria Moreira Beltrão Pereira Brazil Leila Maria Moreira Beltrão Pereira's profile →
Citations per field
00.5×6.1×
Leila Maria Moreira Beltrão Pereira · 1×
Citations per year

Countries citing papers authored by Makie Taal

Since Specialization
Citations

This map shows the geographic impact of Makie Taal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makie Taal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makie Taal more than expected).

Fields of papers citing papers by Makie Taal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makie Taal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makie Taal. The network helps show where Makie Taal may publish in the future.

Co-authorship network of co-authors of Makie Taal

This figure shows the co-authorship network connecting the top 25 collaborators of Makie Taal. A scholar is included among the top collaborators of Makie Taal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makie Taal. Makie Taal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 17
2 3
3 16
4 119
5 256
6 70
7 2
8 29
9 27
10 2
11 14
12 19
13 43
14 3
15 59
16 4
17 110
18 29

About Makie Taal

Makie Taal is a scholar working on Hepatology, Parasitology and Epidemiology, having authored 18 papers that have together received 822 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis C virus research (6 papers). The work is most often cited by research in Hepatology (479 citations), Epidemiology (509 citations) and Parasitology (51 citations). Makie Taal has collaborated with scholars based in Gambia, United Kingdom and France. Frequent co-authors include Umberto D’Alessandro, Mark Thursz, Maud Lemoine, Yusuke Shimakawa, Gibril Ndow, Ramou Njie, Robert Goldin, Shevanthi Nayagam, Harr Freeya Njai and Penda Suso. Their work appears in journals such as PLoS ONE, Gut and Journal of Clinical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026